133 related articles for article (PubMed ID: 22155414)
1. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
2. Niosomal Nanocarriers for Enhanced Skin Delivery of Quercetin with Functions of Anti-Tyrosinase and Antioxidant.
Lu B; Huang Y; Chen Z; Ye J; Xu H; Chen W; Long X
Molecules; 2019 Jun; 24(12):. PubMed ID: 31238562
[TBL] [Abstract][Full Text] [Related]
3. Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study.
Abu Hashim II; Abo El-Magd NF; El-Sheakh AR; Hamed MF; Abd El-Gawad AEH
Int J Nanomedicine; 2018; 13():1059-1079. PubMed ID: 29503541
[TBL] [Abstract][Full Text] [Related]
4. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
Allam A; Fetih G
Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
[TBL] [Abstract][Full Text] [Related]
5. Implementing Central Composite Design for Developing Transdermal Diacerein-Loaded Niosomes: Ex vivo Permeation and In vivo Deposition.
Aziz DE; Abdelbary AA; Elassasy AI
Curr Drug Deliv; 2018; 15(9):1330-1342. PubMed ID: 29921206
[TBL] [Abstract][Full Text] [Related]
6. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Evaluation of Paclitaxel-Loaded PEGylated Niosomes Composed of Sorbitan Esters.
Hosokawa M; Ito S; Noda K; Kono Y; Ogawara KI
Biol Pharm Bull; 2023; 46(10):1479-1483. PubMed ID: 37779050
[TBL] [Abstract][Full Text] [Related]
8. Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation.
Abou-Taleb HA; Khallaf RA; Abdel-Aleem JA
Drug Des Devel Ther; 2018; 12():3501-3516. PubMed ID: 30410310
[TBL] [Abstract][Full Text] [Related]
9. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
Rane BR; Chavan PY; Kate NS; Jain AS
Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil-Loaded Hyaluronic Acid-Coated Niosomal Vesicles: Fabrication and Ex Vivo Evaluation for Skin Drug Delivery.
Khalid W; Shah KU; Saeed MD; Nawaz A; Rehman FU; Shoaib M; Rehman MU; Alasmari AF; Alharbi M; Alasmari F
ACS Omega; 2023 Dec; 8(48):45405-45413. PubMed ID: 38075815
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transdermal delivery of salbutamol sulfate via ethosomes.
Bendas ER; Tadros MI
AAPS PharmSciTech; 2007 Dec; 8(4):E107. PubMed ID: 18181528
[TBL] [Abstract][Full Text] [Related]
12. Transdermal absorption enhancement of rice bran bioactive compounds entrapped in niosomes.
Manosroi A; Chutoprapat R; Abe M; Manosroi W; Manosroi J
AAPS PharmSciTech; 2012 Mar; 13(1):323-35. PubMed ID: 22258804
[TBL] [Abstract][Full Text] [Related]
13. Topical delivery of l-ascorbic acid spanlastics for stability enhancement and treatment of UVB induced damaged skin.
Elhabak M; Ibrahim S; Abouelatta SM
Drug Deliv; 2021 Dec; 28(1):445-453. PubMed ID: 33620008
[TBL] [Abstract][Full Text] [Related]
14. Nanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial design.
de Mattos CB; Argenta DF; Melchiades Gde L; Cordeiro MN; Tonini ML; Moraes MH; Weber TB; Roman SS; Nunes RJ; Teixeira HF; Steindel M; Koester LS
Int J Nanomedicine; 2015; 10():5529-42. PubMed ID: 26366075
[TBL] [Abstract][Full Text] [Related]
15. Span 60/Cholesterol Niosomal Formulation as a Suitable Vehicle for Gallic Acid Delivery with Potent In Vitro Antibacterial, Antimelanoma, and Anti-Tyrosinase Activity.
Zolghadri S; Asad AG; Farzi F; Ghajarzadeh F; Habibi Z; Rahban M; Zolghadri S; Stanek A
Pharmaceuticals (Basel); 2023 Dec; 16(12):. PubMed ID: 38139807
[TBL] [Abstract][Full Text] [Related]
16. Formulation optimization,
Aldawsari MF; Khafagy ES; Moglad EH; Selim Abu Lila A
Saudi Pharm J; 2023 Sep; 31(9):101734. PubMed ID: 37649675
[TBL] [Abstract][Full Text] [Related]
17. Exploring the use of niosomes in cosmetics for efficient dermal drug delivery.
Abu-Huwaij R; Alkarawi A; Salman D; Alkarawi F
Pharm Dev Technol; 2023 Sep; 28(7):708-718. PubMed ID: 37448342
[TBL] [Abstract][Full Text] [Related]
18. Increased cutaneous wound healing effect of biodegradable liposomes containing madecassoside: preparation optimization, in vitro dermal permeation, and in vivo bioevaluation.
Li Z; Liu M; Wang H; Du S
Int J Nanomedicine; 2016; 11():2995-3007. PubMed ID: 27486319
[TBL] [Abstract][Full Text] [Related]
19. Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design.
Solanki AB; Parikh JR; Parikh RH
AAPS PharmSciTech; 2007 Oct; 8(4):E86. PubMed ID: 18181547
[TBL] [Abstract][Full Text] [Related]
20. Formulation, optimization and evaluation of amisulpride-loaded niosomal intranasal gel for brain targeting.
Patil VS; Sutar KP; Pockle RD; Usulkar S; Jadhav VA
Ther Deliv; 2023 Oct; 14(10):635-647. PubMed ID: 38050965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
